Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography
- Autores
- Lucero, Diego Martín; Zago, Valeria; López, Gustavo; Cacciagiú, Leonardo D.; Lopez, Graciela Ines; Wigdorovitz de Wikinski, Regina Luisa; Nakajima, Katsuyuki; Schreier, Laura Ester
- Año de publicación
- 2012
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Objective: To study size heterogeneity of triglyceride rich lipoproteins (TRL) in metabolic syndrome (MS). Design and methods: Thirty MS patients and 14 healthy subjects were included. In fasting serum we measured: lipid profile, free fatty acids (FFA) and adiponectin; TRL were isolated (d < 1.006 g/mL) and analysis by size exclusion HPLC followed by UV detection was performed; each subfraction was expressed as percentage of total TRL. Results: MS patients, even those with normal triglycerides, presented higher proportion of very large VLDL (90. nm diameter) and large VLDL (60. nm) and slightly lower of typical VLDL (37 nm) (p < 0.04); increased FFA (p. =0.04) and lower adiponectin (p=0.001). FFA correlated with large VLDL% (r. =0.58; p. =0.003), independently of insulin-resistance and waist. Furthermore, the lower the adiponectin, the greater the predominance of large VLDL (r. = - 0.40; p. =0.04). Conclusion: MS was associated with large VLDL, described as more atherogenic beyond triglyceride levels. Size exclusion HPLC would represent a useful tool for assessing subfractions' lipoprotein profile. © 2012 Elsevier Inc.
Fil: Lucero, Diego Martín. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Zago, Valeria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: López, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: Cacciagiú, Leonardo D.. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Lopez, Graciela Ines. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Wigdorovitz de Wikinski, Regina Luisa. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
Fil: Nakajima, Katsuyuki. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Gunma University; Japón
Fil: Schreier, Laura Ester. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina - Materia
-
Adiponectin
Free Fatty Acids
Metabolic Syndrome
Size Exclusion Hplc
Triglyceride Rich Lipoproteins
Vldl - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/67279
Ver los metadatos del registro completo
id |
CONICETDig_4a83b1af2d523c0965047f69c38c15a1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/67279 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatographyLucero, Diego MartínZago, ValeriaLópez, GustavoCacciagiú, Leonardo D.Lopez, Graciela InesWigdorovitz de Wikinski, Regina LuisaNakajima, KatsuyukiSchreier, Laura EsterAdiponectinFree Fatty AcidsMetabolic SyndromeSize Exclusion HplcTriglyceride Rich LipoproteinsVldlhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Objective: To study size heterogeneity of triglyceride rich lipoproteins (TRL) in metabolic syndrome (MS). Design and methods: Thirty MS patients and 14 healthy subjects were included. In fasting serum we measured: lipid profile, free fatty acids (FFA) and adiponectin; TRL were isolated (d < 1.006 g/mL) and analysis by size exclusion HPLC followed by UV detection was performed; each subfraction was expressed as percentage of total TRL. Results: MS patients, even those with normal triglycerides, presented higher proportion of very large VLDL (90. nm diameter) and large VLDL (60. nm) and slightly lower of typical VLDL (37 nm) (p < 0.04); increased FFA (p. =0.04) and lower adiponectin (p=0.001). FFA correlated with large VLDL% (r. =0.58; p. =0.003), independently of insulin-resistance and waist. Furthermore, the lower the adiponectin, the greater the predominance of large VLDL (r. = - 0.40; p. =0.04). Conclusion: MS was associated with large VLDL, described as more atherogenic beyond triglyceride levels. Size exclusion HPLC would represent a useful tool for assessing subfractions' lipoprotein profile. © 2012 Elsevier Inc.Fil: Lucero, Diego Martín. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Zago, Valeria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: López, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: Cacciagiú, Leonardo D.. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Lopez, Graciela Ines. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Wigdorovitz de Wikinski, Regina Luisa. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaFil: Nakajima, Katsuyuki. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Gunma University; JapónFil: Schreier, Laura Ester. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; ArgentinaPergamon-Elsevier Science Ltd2012-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/67279Lucero, Diego Martín; Zago, Valeria; López, Gustavo; Cacciagiú, Leonardo D.; Lopez, Graciela Ines; et al.; Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography; Pergamon-Elsevier Science Ltd; Clinical Biochemistry; 45; 4-5; 3-2012; 293-2970009-9120CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0009912011027780info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinbiochem.2011.12.013info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:46:57Zoai:ri.conicet.gov.ar:11336/67279instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:46:57.328CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography |
title |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography |
spellingShingle |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography Lucero, Diego Martín Adiponectin Free Fatty Acids Metabolic Syndrome Size Exclusion Hplc Triglyceride Rich Lipoproteins Vldl |
title_short |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography |
title_full |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography |
title_fullStr |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography |
title_full_unstemmed |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography |
title_sort |
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography |
dc.creator.none.fl_str_mv |
Lucero, Diego Martín Zago, Valeria López, Gustavo Cacciagiú, Leonardo D. Lopez, Graciela Ines Wigdorovitz de Wikinski, Regina Luisa Nakajima, Katsuyuki Schreier, Laura Ester |
author |
Lucero, Diego Martín |
author_facet |
Lucero, Diego Martín Zago, Valeria López, Gustavo Cacciagiú, Leonardo D. Lopez, Graciela Ines Wigdorovitz de Wikinski, Regina Luisa Nakajima, Katsuyuki Schreier, Laura Ester |
author_role |
author |
author2 |
Zago, Valeria López, Gustavo Cacciagiú, Leonardo D. Lopez, Graciela Ines Wigdorovitz de Wikinski, Regina Luisa Nakajima, Katsuyuki Schreier, Laura Ester |
author2_role |
author author author author author author author |
dc.subject.none.fl_str_mv |
Adiponectin Free Fatty Acids Metabolic Syndrome Size Exclusion Hplc Triglyceride Rich Lipoproteins Vldl |
topic |
Adiponectin Free Fatty Acids Metabolic Syndrome Size Exclusion Hplc Triglyceride Rich Lipoproteins Vldl |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Objective: To study size heterogeneity of triglyceride rich lipoproteins (TRL) in metabolic syndrome (MS). Design and methods: Thirty MS patients and 14 healthy subjects were included. In fasting serum we measured: lipid profile, free fatty acids (FFA) and adiponectin; TRL were isolated (d < 1.006 g/mL) and analysis by size exclusion HPLC followed by UV detection was performed; each subfraction was expressed as percentage of total TRL. Results: MS patients, even those with normal triglycerides, presented higher proportion of very large VLDL (90. nm diameter) and large VLDL (60. nm) and slightly lower of typical VLDL (37 nm) (p < 0.04); increased FFA (p. =0.04) and lower adiponectin (p=0.001). FFA correlated with large VLDL% (r. =0.58; p. =0.003), independently of insulin-resistance and waist. Furthermore, the lower the adiponectin, the greater the predominance of large VLDL (r. = - 0.40; p. =0.04). Conclusion: MS was associated with large VLDL, described as more atherogenic beyond triglyceride levels. Size exclusion HPLC would represent a useful tool for assessing subfractions' lipoprotein profile. © 2012 Elsevier Inc. Fil: Lucero, Diego Martín. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina Fil: Zago, Valeria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina Fil: López, Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina Fil: Cacciagiú, Leonardo D.. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina Fil: Lopez, Graciela Ines. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina Fil: Wigdorovitz de Wikinski, Regina Luisa. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina Fil: Nakajima, Katsuyuki. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Gunma University; Japón Fil: Schreier, Laura Ester. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina |
description |
Objective: To study size heterogeneity of triglyceride rich lipoproteins (TRL) in metabolic syndrome (MS). Design and methods: Thirty MS patients and 14 healthy subjects were included. In fasting serum we measured: lipid profile, free fatty acids (FFA) and adiponectin; TRL were isolated (d < 1.006 g/mL) and analysis by size exclusion HPLC followed by UV detection was performed; each subfraction was expressed as percentage of total TRL. Results: MS patients, even those with normal triglycerides, presented higher proportion of very large VLDL (90. nm diameter) and large VLDL (60. nm) and slightly lower of typical VLDL (37 nm) (p < 0.04); increased FFA (p. =0.04) and lower adiponectin (p=0.001). FFA correlated with large VLDL% (r. =0.58; p. =0.003), independently of insulin-resistance and waist. Furthermore, the lower the adiponectin, the greater the predominance of large VLDL (r. = - 0.40; p. =0.04). Conclusion: MS was associated with large VLDL, described as more atherogenic beyond triglyceride levels. Size exclusion HPLC would represent a useful tool for assessing subfractions' lipoprotein profile. © 2012 Elsevier Inc. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/67279 Lucero, Diego Martín; Zago, Valeria; López, Gustavo; Cacciagiú, Leonardo D.; Lopez, Graciela Ines; et al.; Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography; Pergamon-Elsevier Science Ltd; Clinical Biochemistry; 45; 4-5; 3-2012; 293-297 0009-9120 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/67279 |
identifier_str_mv |
Lucero, Diego Martín; Zago, Valeria; López, Gustavo; Cacciagiú, Leonardo D.; Lopez, Graciela Ines; et al.; Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography; Pergamon-Elsevier Science Ltd; Clinical Biochemistry; 45; 4-5; 3-2012; 293-297 0009-9120 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0009912011027780 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinbiochem.2011.12.013 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
publisher.none.fl_str_mv |
Pergamon-Elsevier Science Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613464653299712 |
score |
13.070432 |